Literature DB >> 25650647

The potential of archaeosomes as carriers of pDNA into mammalian cells.

Azade Attar1, Ayse Ogan2, Sevil Yucel3, Kadir Turan3.   

Abstract

This paper describes the formulation of archaeosomes and the evaluation of their abilities to facilitate in vitro DNA delivery. Lipids of the H.hispanica 2TK2 strain were used in archaeosome formation, which is formulated by mixing H.hispanica 2TK2 lipids with plasmid DNA encoding green fluorescent protein (GFP) or β-galactosidase (β-gal). Archaeosome/pDNA formation and unbound DNA were monitored by agarose gel electrophoresis. The archaeosome formulations were visualized by AFM and TEM. The zeta potential analysis showed the archaeosomes to be electronegative. The composition of archaeosomes and the DNA dose for transient transfection into HEK293 cells were optimized, and the relationship between the structure and activity of archaeosomes in DNA delivery was investigated. By themselves, archaeosomes showed low efficiency for DNA delivery, due to their anionic nature. By formulating archaeosomes with a helper molecule, such as DOTAP, CaCl2, or LiCl, the capability of archaeosomes for gene transfection is significantly enhanced. The transfection profiles of efficient archaeosomes are proved to have a long shelf-life when maintained at room temperature. Thus, the archaeal lipids have the potential to be used as transfection reagents in vitro.

Entities:  

Keywords:  Haloarcula hispanica; archaeosome; gene delivery; in vitro transfection; lipid extraction

Mesh:

Substances:

Year:  2015        PMID: 25650647     DOI: 10.3109/21691401.2014.982800

Source DB:  PubMed          Journal:  Artif Cells Nanomed Biotechnol        ISSN: 2169-1401            Impact factor:   5.678


  1 in total

1.  Transfection Studies with Colloidal Systems Containing Highly Purified Bipolar Tetraether Lipids from Sulfolobus acidocaldarius.

Authors:  Konrad H Engelhardt; Shashank Reddy Pinnapireddy; Elias Baghdan; Jarmila Jedelská; Udo Bakowsky
Journal:  Archaea       Date:  2017-01-23       Impact factor: 3.273

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.